Development of a Scalable and Practical Synthesis of AB928, a Dual A2a/A2b Receptor Antagonist

AB928 is a potent and selective dual antagonist of the A2a and A2b receptors, which is currently in clinical trials. Here, we report the development of two scalable and practical syntheses of AB928...